The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of programmed cell death protein 1 (PD1) inhibitors in cutaneous squamous cell carcinoma (cSCC) patients with large nerve-perineural invasion (LN-PNI): A multicenter retrospective study.
 
Prajwol Shrestha
No Relationships to Disclose
 
Rahul Ladwa
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - AstraZeneca; Roche
Travel, Accommodations, Expenses - MSD
 
Gillian Heller
No Relationships to Disclose
 
Tsu-Hui (Hubert) Low
No Relationships to Disclose
 
Carsten Palme
Stock and Other Ownership Interests - Nyxoah
Consulting or Advisory Role - Nyxoah
 
Kerwin Frank Shannon
No Relationships to Disclose
 
Karen P. Briscoe
No Relationships to Disclose
 
Faisal Hayat
No Relationships to Disclose
 
Jonathan Clark
Stock and Other Ownership Interests - Singular Health
Consulting or Advisory Role - Singular Health
 
Ruta Gupta
No Relationships to Disclose
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche; Sanofi/Aventis; Takeda
Research Funding - Amgen (Inst)
 
Jenny HJ Lee
Honoraria - Bristol-Myers Squibb; MSD; Sanofi
Consulting or Advisory Role - MSD; Sanofi
Research Funding - MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis